These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21762505)

  • 21. B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients.
    Lovett-Racke AE; Gormley M; Liu Y; Yang Y; Graham C; Wray S; Racke MK; Shubin R; Twyman C; Alvarez E; Bass A; Eubanks JL; Fox E
    J Neuroimmunol; 2019 Jul; 332():187-197. PubMed ID: 31077854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients.
    Chiarini M; Capra R; Serana F; Bertoli D; Sottini A; Giustini V; Scarpazza C; Rovaris M; Torri Clerici V; Ferraro D; Galgani S; Solaro C; Conti MZ; Visconti A; Imberti L;
    J Transl Med; 2020 Apr; 18(1):169. PubMed ID: 32299447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
    J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers.
    Ferrandi C; Richard F; Tavano P; Hauben E; Barbié V; Gotteland JP; Greco B; Fortunato M; Mariani MF; Furlan R; Comi G; Martino G; Zaratin PF
    Mult Scler; 2011 Jan; 17(1):43-56. PubMed ID: 20855355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis.
    Mikulkova Z; Praksova P; Stourac P; Bednarik J; Michalek J
    J Neurol Sci; 2011 Jan; 300(1-2):135-41. PubMed ID: 20884014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis.
    Azimi M; Ghabaee M; Moghadasi AN; Noorbakhsh F; Izad M
    Immunol Res; 2018 Aug; 66(4):513-520. PubMed ID: 29882035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
    Levy YA; Fainberg KM; Amidror T; Regev K; Auriel E; Karni A
    J Neuroimmunol; 2013 Apr; 257(1-2):82-9. PubMed ID: 23466131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Caggiula M; Marti A; Sancricca C; Angelucci F; Mirabella M; Tonali PA; Batocchi AP
    Immunology; 2009 Jul; 127(3):418-28. PubMed ID: 19016907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
    Haas J; Hug A; Viehöver A; Fritzsching B; Falk CS; Filser A; Vetter T; Milkova L; Korporal M; Fritz B; Storch-Hagenlocher B; Krammer PH; Suri-Payer E; Wildemann B
    Eur J Immunol; 2005 Nov; 35(11):3343-52. PubMed ID: 16206232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.
    Malhotra S; Villar LM; Costa C; Midaglia L; Cubedo M; Medina S; Fissolo N; Río J; Castilló J; Álvarez-Cermeño JC; Sánchez A; Montalban X; Comabella M
    J Neuroinflammation; 2018 Oct; 15(1):296. PubMed ID: 30367633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis.
    Stühler E; Braune S; Lionetto F; Heer Y; Jules E; Westermann C; Bergmann A; van Hövell P;
    BMC Med Res Methodol; 2020 Feb; 20(1):24. PubMed ID: 32028898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic output and peripheral T lymphocyte subsets in relapsing--remitting multiple sclerosis patients treated or not by IFN-beta.
    Puissant-Lubrano B; Viala F; Winterton P; Abbal M; Clanet M; Blancher A
    J Neuroimmunol; 2008 Jan; 193(1-2):188-94. PubMed ID: 18068811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis.
    Grau-López L; Raïch D; Ramo-Tello C; Naranjo-Gómez M; Dávalos A; Pujol-Borrell R; Borràs FE; Martínez-Cáceres E
    Eur J Neurol; 2011 Aug; 18(8):1101-4. PubMed ID: 21749576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity.
    Breuer J; Schwab N; Schneider-Hohendorf T; Marziniak M; Mohan H; Bhatia U; Gross CC; Clausen BE; Weishaupt C; Luger TA; Meuth SG; Loser K; Wiendl H
    Ann Neurol; 2014 May; 75(5):739-58. PubMed ID: 24771567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of circulating gamma-delta T cells in relapsing vs remission multiple sclerosis.
    Monteiro A; Cruto C; Rosado P; Martinho A; Rosado L; Fonseca M; Paiva A
    J Neuroimmunol; 2018 May; 318():65-71. PubMed ID: 29506867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances.
    Bar-Or A; Li R
    Lancet Neurol; 2021 Jun; 20(6):470-483. PubMed ID: 33930317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis.
    Hintzen RQ; Pot K; Paty D; Oger J
    Acta Neurol Scand; 2000 Jan; 101(1):57-60. PubMed ID: 10660154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
    Rodi M; Dimisianos N; de Lastic AL; Sakellaraki P; Deraos G; Matsoukas J; Papathanasopoulos P; Mouzaki A
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.